Bluebird 'Potentially The Walter White Of CAR T Therapy,' Says BTIG

By: via Benzinga
After market close on Wednesday, bluebird bio Inc (NASDAQ: BLUE) released early data on the relapsed/refractory multiple myeloma study. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.